Study Site — Little Rock, Arkansas

Study Site is a clinical research site located in Little Rock, Arkansas, United States 72211.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Study Site has participated in 4 clinical trials with 1 currently active.

Therapeutic areas: Schizophrenia, Type 2 Diabetes, Hereditary Angioedema (HAE).

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc., Intarcia Therapeutics, Pharvaris Netherlands B.V..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Study Site?

Study Site has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Study Site conducted?

Study Site has 4 clinical trials on record, with 1 currently active. Their work covers Schizophrenia, Type 2 Diabetes, Hereditary Angioedema (HAE).

Is Study Site accredited by Crixeo Health?

Yes — Study Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Study Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.